|
Central America Generic Drugs News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Central America Pharmaceuticals.
Latest Central America Generic Drugs News
- H1N1 is now world's dominant flu virus, WHO says 6 Nov 2009 13:00 GMT
... as Cuba and Haiti, he said. In Central America and the Southern Hemisphere, however, activity levels ... instances of resistance to oseltamivir -- the generic name for Tamiflu, one of the main drugs used against influenza -- but such cases are ...
- "I believe a president should focus on the masses and not on the elite" 6 Nov 2009 06:13 GMT
... peace with its workers´ union. The international pharmaceutical industry was also endangered by Zelaya´s government, ... which had been signing agreements for cheaper, generic drugs. These savings could have favored a public ...
- India plans tit for tat as Argentina bars pharma cos 3 Nov 2009 21:32 GMT
... Wary that Argentina's insistence on blocking Indian generics could come in the way of the Indian pharma industry's plans in Latin America, the Centre ... countries, Argentina, by not letting in Indian drugs, could also set an example for other ...
- BUYINS.NET: EP, ATPG, SVNT, IFLO, HIBB, OREX Expected To Be Lower Leading Up To Next Earnings Releases 3 Nov 2009 09:37 GMT
... ATP Oil and Gas (NASDAQ: ATPG), Savient Pharmaceuticals (NASDAQ: SVNT), I-flow Corp (NASDAQ: IFLO), Hibbett ... The company sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary ...
- WHO: H1N1 is now world's dominant flu virus 5 Nov 2009 17:25 GMT
... as Cuba and Haiti, he said. In Central America and the Southern Hemisphere, however, activity levels ... instances of resistance to oseltamivir -- the generic name for Tamiflu, one of the main drugs used against influenza -- but such cases are ...
- Valeant Pharmaceuticals International Q3 2009 Earnings Call Transcript 2 Nov 2009 21:12 GMT
... De Silva, chief operating officer of Specialty Pharmaceuticals. In addition to a live webcast, a ... we expected, what matters is when a drug gets approved, not when it is submitted. ... due in part to the inclusion of generic BenzaClin and the total contributed $34 million ...
- Valeant Pharmaceuticals Reports Third Quarter Financial Results 2 Nov 2009 13:55 GMT
... VIEJO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced third quarter ... quarter of 2008. Product sales in Branded Generics - Latin America were $40.7 million in ... collaboration partner GSK, completed both the New Drug Application (NDA) and the Marketing Authorisation Application ...
- John Pilger: Peace awards and Obama's wars 1 Nov 2009 06:53 GMT
... farmers, cut back interest rates and reduced poverty. He planned to break a US pharmaceutical monopoly and manufacture cheap generic drugs. Obama has called for Zelaya’s reinstatement, but refuses to condemn the coup-makers, or recall ...
- HEADLINE STOCKS-Some U.S. stocks on the move on Nov. 3 3 Nov 2009 19:34 GMT
... reported adjusted third-quarter earnings that beat expectations and raised its 2009 profit view. TEVA PHARMACEUTICALS INDUSTRIES INC, $50.01, down 2.3 pct The generic drugmaker reported adjusted third-quarter earnings that beat expectations by a penny. EMERSON ELECTRIC CO, $38.72, ...
- Perrigo Sells Consumer Product Unit 3 Nov 2009 19:35 GMT
... Company develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and ... and logistics operations are the U.S., Israel, Mexico and the UK. ...
- Perrigo Company Divests Israel Cosmetics Business for 205 Million New Israeli Shekels 2 Nov 2009 12:30 GMT
... that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and ... logistics operations are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on ...
- US Stocks Helped By Rallying Transports 3 Nov 2009 22:20 GMT
... down 3.45, or 1.6%, to 219.20. Royal Caribbean Cruises lost 92 cents, or 4.5%, to ... fiscal fourth-quarter earnings rose 13% as the drug wholesaler reported what President and Chief Executive R. David ... Yost said was above-market sales growth in generic drugs. Shares closed up 69 cents, or ...
- AES, PRX, TNP, TEO, MFW, MDCI Expected To Be Higher After Earnings Releases on Friday 4 Nov 2009 09:27 GMT
... earnings reports. AES Corp (NYSE: AES), Par Pharmaceuticals (NYSE: PRX), Tsakos Energy (NYSE: TNP), Telecom ... Par Pharmaceutical, Inc. develops, manufactures, and distributes generic and branded pharmaceuticals drugs in the United States. Its principal generic ...
- BUYINS.NET: AES, PRX, TNP, TEO, MFW, MDCI Expected To Be Higher After Earnings Releases on Friday 3 Nov 2009 19:37 GMT
... earnings reports. AES Corp (NYSE: AES), Par Pharmaceuticals (NYSE: PRX), Tsakos Energy (NYSE: TNP), Telecom ... Par Pharmaceutical, Inc. develops, manufactures, and distributes generic and branded pharmaceuticals drugs in the United States. Its principal generic ...
- Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 2 Nov 2009 12:50 GMT
... final approval from the U.S. Food and Drug Administration (FDA) to market OTC Polyethylene Glycol ... store brand equivalent of MiraLAX®. The Rx Pharmaceuticals segment first quarter net sales were $47 ... Israeli subsidiary acquired the ANDA for the generic form of Duac® gel from KV Pharmaceutical ...
Powered by 
Central America Pharmaceuticals News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Pharmaceutical Industry Today
|
a digital news provider
bloomberg.com:
healthday.com:
msnbc.msn.com: